DEPDC1 as a crucial factor in the progression of human osteosarcoma

ConclusionsCollectively, this study demonstrated thatDEPDC1 is a critical driver in the promotion of osteosarcoma progression and results in poor patient prognosis. Genetically targeting or pharmacologically inhibitingDEPDC1 may serve as a promising strategy for treating human osteosarcoma.

Source: Cancer Medicine - December 7, 2022 Category: Cancer & Oncology Authors: Lin Shen, Han Li, Ronghan Liu, Chendan Zhou, Morgan Bretches, Xuan Gong, Laitong Lu, Ying Zhang, Kai Zhao, Bin Ning, Shang ‐You Yang, Aijun Zhang Tags: RESEARCH ARTICLE Source Type: research